[artículo] 
inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 301-310

Título :	Ziprasidone in acute bipolar mania : A 21-day randomized, double blind, placebo controlled replication trial
Tipo de documento:	texto impreso
Autores:	Steven G. Potkin, Autor ; Paul E. Keck, Autor ; Scott Segal, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 301-310
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Enfermedad aguda, Antipsicóticos, Trastorno bipolar, Hospitalización, Piperazinas, Tiazoles.
Resumen:	In an earlier 21-day, placebo-controlled trial, ziprasidone was efficacious in improving symptoms of mania and was well tolerated. To confirm these results, a similarly designed 21-day trial was conducted.
Link:	./index.php?lvl=notice_display&id=30894

[artículo] Ziprasidone in acute bipolar mania : A 21-day randomized, double blind, placebo controlled replication trial [texto impreso] / Steven G. Potkin, Autor ; Paul E. Keck, Autor ; Scott Segal, Autor . - 2023 . - pp. 301-310.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 301-310

Palabras clave:	Enfermedad aguda, Antipsicóticos, Trastorno bipolar, Hospitalización, Piperazinas, Tiazoles.
Resumen:	In an earlier 21-day, placebo-controlled trial, ziprasidone was efficacious in improving symptoms of mania and was well tolerated. To confirm these results, a similarly designed 21-day trial was conducted.
Link:	./index.php?lvl=notice_display&id=30894